Melatonin protects from ischemia/reperfusion-induced renal injury in rats: This effect is not mediated by proinflammatory cytokines

Journal of Pineal Research

Volumn 43, Issue 2, 2007, Pages 172-178

  Kurcer, Zehra ^a   Oguz, Elif ^a   Ozbilge, Hatice ^b   Baba, Fusun ^a   Aksoy, Nurten ^a   Çelik, Hakim ^a   Çakr, Hale ^a   Gezen, Mehmet Riza ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Cytokines; Ischemia; Kidney; Melatonin; Oxidative stress; Reperfusion

Indexed keywords

CREATININE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HISTOLOGY; INFLAMMATION; ISCHEMIA; KIDNEY INJURY; MALE; MODULATION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CREATINE; CYTOKINES; KIDNEY; MALE; MELATONIN; NITROGEN; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 34447534361     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00459.x     Document Type: Article

References (52)

1. Paller MS. Acute renal failure: controversies, clinical trials, and future directions. Semin Nephrol 1998 18 : 482 489.
2. Reiter RJ, Tan DX, Gitto E et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 2004 56 : 159 170.
3. Meldrum DR, Cleveland JC, Sheridan BC et al. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Throrac Surg 1996 61 : 1273 1280.
4. Weight SC, Bell PRF, Nicholson ML. Renal ischemia-reperfusion injury. Br J Surg 1996 83 : 162 170.
5. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol Heart Circ Physiol 1983 244 : H743 H748.
6. Lauriat S, Linas SL. The role of neutrophils in acute renal failure. Semin Nephrol 1998 18 : 498 504.
7. Paller MS, Hoidal J, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984 74 : 1156 1164.
8. Kelly KJ, Williams WW, Colvin RB et al. Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J Clin Invest 1996 97 : 1056 1063.
9. Meldrum KK, Meldrum DR, Meng X, Ao L, Harken AH. TNF-α-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2002 282 : H540 H546.
10. Donnahoo KK, Meldrum DR, Shenkar R et al. Early renal ischemia, with or without reperfusion, activates NfkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000 163 : 1328 1332.
11. Han SL, Yu LX, Ma JJ et al. Effect of anti-tumor necrosis factor-alpha monoclonal antibody in alleviating renal ischemia reperfusion injury. Di Yi Jun Yi Da Xue Xue Bao 2003 23 : 332 334.
12. Zager RA, Johnson ACM, Hanson SY, Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-α generation and systemic release. Am J Physiol Renal Physiol 2005 289 : F289 F297.
13. Kilic E, Ozdemir YG, Bolay H et al. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 1999 19 : 511 516.
14. Lagneux C, Joyeux M, Demenge P et al. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000 66 : 503 509.
15. Sahna E, Acet A, Ozer MK, Olmez E. Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res 2002 33 : 234 238.
16. Sener G, Sehirli AO, Keyer-Uysal M et al. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res 2002 32 : 120 126.
17. Sahna E, Parlakpinar H, Ozturk F et al. The protective effects of on renal ischemia-reperfusion injury in rats. Urol Res 2003 31 : 188 193.
18. Rodriguez-Reynoso S, Leal C, Portilla-de-Buen E et al. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res 2004 116 : 242 247.
19. Rodriguez-Reynoso S, Leal C, Portilla-de-Buen E, Olivares N. Effects of exogenous melatonin on hepatic energetic status during ischemia-reperfusion: possible role of TNF-α and nitric oxide. J Surg Res 2001 110 : 141 149.
20. Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
21. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
22. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulating effect of melatonin on antioxidative enzymes. J Pineal Res 2005 39 : 99 104.
23. Gitto E, Romeo C, Reiter RJ et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004 39 : 184 189.
24. Silva SO, Rodrigues MR, Ximenes VF et al. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 2004 156 : 146 152.
25. Mayo JC, Sainz RM, Tan DX et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005 165 : 139 149.
26. Silva SO, Maria R, Rodrigues SR et al. Oxidation of melatonin and its catabolites, N1-acetyl-N2-formyl-5-methoxykynuramine and N1-acetyl-5- methoxykynuramine, by activated leukocytes. J Pineal Res 2004 37 : 171 175.
27. Perianayagam MC, Oxenkrug GF, Jaber BL. Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine. Ann N Y Acad Sci 2005 1053 : 386 393.
28. Irmak MK, Koltuksuz U, Kutlu NO et al. The effect of caffeic acid phehethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 2001 29 : 190 193.
29. Esterbauer H, Cheeseman KH. Methods in enzymology. In : Determination of Aldehydic Lipid Peroxidation Products: Malonaldehyde and 4-Hydroxynonenal; Oxygen Radicals in Biological Systems. Packer L, Glazer AN, eds. Academic Press, California, 1990 pp. 407 421.
30. Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993 14 : 1195 1201.
31. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABT Sradicalcation. Clin Biochem 2004 37 : 277 285.
32. Miyazawa T. Determination of phospholipid hydroperoxides in 381 human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 1989 7 : 209 217.
33. Harma M, Harma M, Erel O. Increased oxidative stress in patients 372 with hydatidiform mole. Swiss Med Wkly 2003 133 : 563 566.
34. Kang DH, Kim YG, Andoh TF et al. Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol 2001 280 : F727 F736.
35. Erdogan H, Fadillioglu E, Yagmurca M et al. Protein oxidation and lipid peroxidation after renal ischemia reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006 34 : 41 46.
36. Holmberg SR, Cumming DV, Kusoma Y et al. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience 1991 2 : 19 25.
37. Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to cellular antioxidative defense mechanism. Horm Metab Res 1997 29 : 363 372.
38. Reiter RJ, Tang I, Garcia JJ, Munoz HA. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997 60 : 2255 2271.
39. Tan DX, Manchester LC, Burkhardt S et al. N1-acetyl-N2-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001 15 : 2294 2296.
40. Guenther AL, Schmidt SI, Laatsch H et al. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnoli none and 3-nitro-AMK. J Pineal Res 2005 39 : 251 260.
41. Tan DX, Manchester LC, Terran MR et al. The molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 2001 42 : 28 42.
42. Eschwege P, Paradis V, Conti M et al. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol 1999 162 : 553 557.
43. Weiss SJ, Ward PA. Immune complex-induced generation of oxygen metabolites by human neutrophils. J Immunol 1982 129 : 309 319.
44. Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000 190 : 255 266.
45. Ysebaert DK, De Greef KE, Vercauteren SR et al. Identification and kinetics of leukocytes after severe ischemia/reperfusion renal injury. Nephrol Dial Transplant 2000 15 : 1562 1574.
46. Lien YHH, Lai LW, Silva AL. Pathogenesis of renal ischemia reperfusion injury: lessons from knock out mice. Life Sci 2003 74 : 542 552.
47. Donnahoo KK, Meng X, Ayala A et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999 277 : R922 929.
48. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003 14 : 1549 1558.
49. Kielar ML, John R, Bennett M et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005 16 : 3315 3325.
50. Jo SK, Sung SA, Cho WY et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006 21 : 1231 1239.
51. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994 15 : 74 80.
52. Hoke TS, Douglas IS, Klein CL et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007 18 : 155 1564.